MedTrace Logo

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

NCT03304444 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2017-10-09

No results posted yet for this study

Summary

This study evaluates the comparison between liposomal bupivacaine versus bupivacaine HCl in Transversus Abdominis Plane blocks for gynecologic surgery on the length of stay in the hospital, total narcotic use, and overall complications rates.

Conditions

  • Gynecologic Cancer
  • Post Operative Pain

Interventions

DRUG

Bupivacaine

bupivacaine hydrochloride used in TAP block

DRUG

liposomal bupivacaine

liposomal bupivacaine used in TAP block

Sponsors & Collaborators

  • Abington Memorial Hospital

    lead OTHER

Principal Investigators

  • Heidi Ching, MD · OB GYN Resident

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03304444 on ClinicalTrials.gov